Development of Multidrug Resistant Tuberculosis in Bangladesh: A Case-Control Study on Risk Factors

被引:52
作者
Rifat, Mahfuza [1 ,2 ]
Milton, Abul Hasnat [1 ]
Hall, John [1 ]
Oldmeadow, Christopher [1 ]
Islam, Md. Akramul [2 ]
Husain, Ashaque [3 ]
Akhanda, Md. Wahiduzzaman [4 ]
Siddiquea, Bodrun Naher [2 ]
机构
[1] Univ Newcastle, Newcastle, NSW 2300, Australia
[2] BRAC, Dhaka, Bangladesh
[3] Directorate Gen Hlth Serv, Natl TB Control Programme, Dhaka, Bangladesh
[4] Natl Inst Dis Chest & Hosp, Dhaka, Bangladesh
关键词
DRUG-RESISTANCE; PREVALENCE; POPULATION;
D O I
10.1371/journal.pone.0105214
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: To determine the risk factors for developing multidrug resistant tuberculosis in Bangladesh. Methods: This case-control study was set in central, district and sub-district level hospitals of rural and urban Bangladesh. Included were 250 multidrug resistant tuberculosis (MDR-TB) patients as cases and 750 drug susceptible tuberculosis patients as controls. We recruited cases from all three government hospitals treating MDR-TB in Bangladesh during the study period. Controls were selected randomly from those local treatment units that had referred the cases. Information was collected through face-to-face interviews and record reviews. Unadjusted and multivariable logistic regression were used to analyse the data. Results: Previous treatment history was shown to be the major contributing factor to MDR-TB in univariate analysis. After adjusting for other factors in multivariable analysis, age group "18-25'' (OR 1.77, CI 1.07-2.93) and "26-45'' (OR 1.72, CI 1.12-2.66), some level of education (OR 1.94, CI 1.32-2.85), service and business as occupation (OR 2.88, CI 1.29-6.44; OR 3.71, CI 1.59-8.66, respectively), smoking history (OR 1.58, CI 0.99-2.5), and type 2 diabetes (OR 2.56 CI 1.51-4.34) were associated with MDR-TB. Previous treatment was not included in the multivariable analysis as it was correlated with multiple predictors. Conclusion: Previous tuberculosis treatment was found to be the major risk factor for MDR-TB. This study also identified age 18 to 45 years, some education up to secondary level, service and business as occupation, past smoking status, and type 2 diabetes as comorbid illness as risk factors. National Tuberculosis programme should address these risk factors in MDR-TB control strategy. The integration of MDR-TB control activities with diabetes and tobacco control programmes is needed in Bangladesh.
引用
收藏
页数:7
相关论文
共 36 条
[1]   Predictors of Multidrug- and Extensively Drug-Resistant Tuberculosis in a High HIV Prevalence Community [J].
Andrews, Jason R. ;
Shah, N. Sarita ;
Weissman, Darren ;
Moll, Anthony P. ;
Friedland, Gerald ;
Gandhi, Neel R. .
PLOS ONE, 2010, 5 (12)
[2]  
[Anonymous], 2007, A WHO/The Union monograph on TB and tobacco control: joining efforts to control two related global epidemics
[3]  
[Anonymous], GLOB TUB REP 2013
[4]  
[Anonymous], 2012, Annual Report
[5]  
[Anonymous], 2013, UNAIDS REP GLOB AIDS
[6]   Increasing Prevalence of Type 2 Diabetes in a Rural Bangladeshi Population: A Population Based Study for 10 Years [J].
Bhowmik, Bishwajit ;
Afsana, Faria ;
Diep, Lien My ;
Munir, Sanjida Binte ;
Wright, Erica ;
Mahmood, Sharif ;
Khan, A. K. Azad ;
Hussain, Akhtar .
DIABETES & METABOLISM JOURNAL, 2013, 37 (01) :46-53
[7]   Self-Reported Risks for Multiple-Drug Resistance among New Tuberculosis Cases: Implications for Drug Susceptibility Screening and Treatment [J].
Brewer, Timothy F. ;
Choi, Howard W. ;
Seas, Carlos ;
Krapp, Fiorella ;
Zamudio, Carlos ;
Shah, Lena ;
Ciampi, Antonio ;
Heymann, S. Jody ;
Gotuzzo, Eduardo .
PLOS ONE, 2011, 6 (10)
[8]  
Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382
[9]  
Caminero JA., 2013, Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis
[10]   A case-control study for multidrug-resistant tuberculosis:: Risk factors in four European countries [J].
Casal, M ;
Vaquero, M ;
Rinder, H ;
Tortoli, E ;
Grosset, J ;
Rüsch-Gerdes, S ;
Gutiérrez, J ;
Jarlier, V .
MICROBIAL DRUG RESISTANCE, 2005, 11 (01) :62-67